Editorial Staff

  • Executive Editor/VP-Special Projects:
    Jeff Hall
  • Senior Editor
    Brian McCurdy
  • Circulation and Subscriptions
    Bonnie Shannon
  • Art Director:
    Alana Balboni
  • Editorial Correspondence

  • Jeff Hall, Executive Editor/VP-Special Projects, Podiatry Today
  • HMP Communications, 83 General Warren Blvd
    Suite 100, Malvern PA 19355
  • Telephone: (800) 237-7285, ext. 214
    Fax: (610) 560-0501
  • Email: jhall@hmpcommunications.com
  • March 2005 | Volume 18 - Issue 3

    4,094 reads | 0 comments | 09/03/08
       Babak Baravarian, DPM, first of all, I want to say I always find your articles very educational and informative. As a CryoStar cryoanalgesic certified podiatrist with over 100 clinical cases under my wings, I wanted to add my spin on interdigital neuritis to your perspective (see “How To Diagnose And Treat Interdigital Neuritis,” page 67, January issue).    The use of cyroablation for treatment of Morton’s neuromas received FDA approval in June of 2003. With my colleague, Lawrence Fallat, DPM, and the other 19 CryoStar surgeons, we have treated well o... continue reading
    Gabapentin is currently undergoing placebo-controlled studies for the treatment of diabetic neuropathy and other disorders.
    By Stephanie Wu, DPM
    33,918 reads | 0 comments | 09/03/08
       Neuropathy is a common and debilitating complication of diabetes mellitus. According to data compiled by the National Institute of Diabetes and Digestive and Kidney Disease (NIDDK) and the American Diabetes Association (ADA), roughly 60 to 70 percent of the 18.2 million Americans with diabetes will develop some form of diabetic neuropathy and about 3 million patients with diabetes will experience painful neuropathy.    There are three broad types of neuropathy (sensory, motor and autonomic) associated with diabetes. Sensory neuropathy is the most prevalent ... continue reading

    5,952 reads | 0 comments | 09/03/08
    A Step Toward A Perfect Fit    The newest product for digital foot scanning expands on previously developed technology.    The iStep Footwear Integration Technology (FIT) expands on the iStep Pressure Plate, a computer system that measures arch type and pressure points as a patient walks, according to Apex Foot Health Industries, the manufacturer of both products.    The company’s patented FIT is particularly valuable in retail as the technology allows one to categorize patients based on their foot measurements, arch types and ... continue reading
    By Peter M. Wilusz, DPM, Guy R. Pupp, DPM, and Molly Judge, DPM
    10,734 reads | 0 comments | 09/03/08
    Yes, these authors say early identification of the Charcot process and prompt surgical intervention can prevent progression of the deformity and related complications. By Peter M. Wilusz, DPM and Guy R. Pupp, DPM    The presentation of Charcot neuroarthropathy has been historically problematic for the foot and ankle surgeon. Acute Charcot has traditionally been treated with conservative therapy as most attempts at treatment involve immobilization and removal of weightbearing forces from the involved foot. Many surgeons do not surgically address the acute Char... continue reading
    Here one can see hemodynamically significant stenosis at the origin of the left anterior tibial artery.
    By John E. Aruny, MD, Peter Blume, DPM, Bauer Sumpio, MD, PhD, and Benjamin Buren, DPM
    13,688 reads | 0 comments | 09/03/08
       Chronic critical limb ischemia has been defined as a non-healing ulceration or gangrene of the foot or toes, and/or rest pain that requires regular use of analgesics.1 These patients will require some type of intervention to resolve their condition. It can be particularly challenging to salvage the limb of a patient who has failed a bypass. The objective of revascularization is to augment blood flow to allow for wound healing and avoid major amputation resulting in the need for a prosthesis.    Amputation of one or more digits or even transmetatar... continue reading
    By Robert Smith, Contributing Editor
    4,014 reads | 0 comments | 09/03/08
       When a practice’s bottom line is not as strong as it should be, one should take a serious look at overhead costs but it is also important to look at how you and your staff are doing your jobs. There are things podiatrists can do to make more efficient use of staff, technology and process, and accordingly rein in runaway costs. Indeed, there are few practices out there that could not benefit financially from being more efficient.     “The idea is to look from the outside in,” says Hal Ornstein, DPM. “You are always inside the operation and you cannot ... continue reading
    By Babak Baravarian, DPM
    30,131 reads | 0 comments | 09/03/08
       Problems with the lateral column are more common than we believe. Although there is a great deal of understanding of medial column problems and their solutions, there is not as much information on lateral column symptoms, causes and treatment options. With this in mind, let us take a closer look at these potential symptoms and treatment options that our institute has found helpful for such problems.    A typical patient may have an equinus and pain in the lateral foot and ankle. The pain is localized to the rearfoot and lateral ankle with tenderness along th... continue reading
    Here one can see well-adhered ischemic eschar. The authors used conservative care including topical enzymatic agents until the eschar began to slough around the periphery.
    By Jonathan Moore, DPM, and Pamela Jensen, DPM
    38,302 reads | 0 comments | 09/03/08
       Diabetic heel ulcers constitute one of the most frustrating problems for podiatric physicians. Pressure ulcers affect nearly 2 million people each year and account for annual healthcare costs that range between $2.2 billion and $3.6 billion. The heel is the second leading site for development of pressure ulcers after the sacrum.1 While patients with diabetes are living longer than in the past, the incidence of hospital-acquired heel ulcers increased from 19 percent in 1989 to 30 percent in 1993.2    Costs for heel ulcers are nearly dou... continue reading
    Seventh in a series
    By Brian McCurdy, Associate Editor
    6,630 reads | 0 comments | 09/03/08
       The potential side effects of nonsteroidal antiinflammatory drugs (NSAIDs), including COX-2 inhibitors, have been well documented recently. The highly publicized Public Health Advisory from the Food and Drug Administration on celecoxib (Celebrex) and rofecoxib (Vioxx) has increased the discussion about the safety of such agents. What types of side effects should one be wary of with NSAIDs and COX-2 inhibitors, and what screening precautions can one take?    Nicholas Grumbine, DPM, has seen gastrointestinal (GI) difficulties and bleeding in patients taking ... continue reading
    By Jeff Hall, Executive Editor
    2,101 reads | 0 comments | 09/03/08
       Over 18 percent of people age 60 and over in the United States have diabetes. According to the American Diabetes Association, 1.3 million new cases of diabetes are diagnosed every year in people over the age of 20. Between 60 to 70 percent of people with diabetes have mild to severe forms of nervous system damage, a major contributing factor to lower-extremity amputation. Greater than 60 percent of nontraumatic lower-limb amputations in the U.S. occur among patients with diabetes.    With these statistics in mind, we present our Fifth Annual Diabetes theme ... continue reading